Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes
Catherine C. Robertson, Jamie R. J. Inshaw, Suna Önengüt-Gümüşcü, Wei‐Min Chen, David Flores Santa Cruz, Hanzhi Yang, Antony J. Cutler, Daniel J. M. Crouch, Emily Farber, S. Louis Bridges, Jeffrey C. Edberg, Robert P. Kimberly, Jane Hoyt Buckner, Panos Deloukas, Jasmin Divers, , Stephen S. Rich
This study identifies causal variants, cells, genes, and drug targets for type 1 diabetes using large-scale genetic and functional genomic analyses.
Nature Genetics · Jun 14, 2021Peer-reviewedGenetics